Flecainide-Associated Cardiogenic Shock in a Patient with Atrial Fibrillation

Flecainide is a frequently used antiarrhythmic drug, recommended by current guidelines as a first-line treatment option for restoring and maintaining sinus rhythm in patients with atrial fibrillation and no significant structural heart disease. In overdose, it can induce severe cardiogenic shock. Ca...

Full description

Bibliographic Details
Main Authors: Erind Gjermeni, Andreas Bollmann, Gerhard Hindricks, Andreas Müssigbrodt
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Case Reports in Cardiology
Online Access:http://dx.doi.org/10.1155/2019/4820652